U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Substance Use Tools & Resources   

Read the Guide

This collection of tools and resources is for providers, staff, and patients who offer or use services to address substance use, and other interested stakeholders. This collection was originally established following an environmental scan on implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care. (See PDFs of Volume 1 [PDF 0.69 MB] and Volume 2 [PDF 1.28 MB] of that scan). Items have been continuously added to this collection since then, and the collection has expanded to cover substance use more broadly, rather than just MAT for OUD.

Displaying 31 - 40 of 126

NIH HEAL Initiative

The Helping to End Addiction Long-term Initiative, or NIH HEAL Initiative, is an aggressive, trans-agency effort to speed scientific solutions to stem the national opioid public health crisis.
Format
Campaign
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Policymakers and Payers
Source
National Institutes of Health (NIH)
Year
Resource Type
Web Page

The FDA SOURCE Model

The primary objectives of the SOURCE (Simulation of Opioid Use, Response, Consequences, and Effects) model are threefold: help the FDA and other stakeholders identify high-impact opioid-related interventions, assess potential unanticipated consequences of potential policies, and identify needs for further research.
Format
Instrument/Protocol
Audience
States
Policymakers and Payers
Source
Food and Drug Administration (FDA)
Year
Resource Type
Web Page

A Practical Research Agenda for Treatment Development for Stimulant Use Disorder

This was a virtual public workshop to discuss a practical research agenda toward treatment development for stimulant use disorder. Meeting participants responded to a proposed practical research agenda that focuses on innovation in clinical trial design and candidate endpoints for the evaluation of potential treatments for stimulant use disorder.
Format
Webinar/Video
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Source
Reagan-Udall Foundation for the FDA (Food and Drug Administration)
Year
Resource Type
Video

ACPA – Stanford Resource Guide To Chronic Pain Management: An Integrated Guide to Comprehensive Pain Therapies

The ACPA Resource Guide to Chronic Pain Management combines practical clinical experience and the most recent scientific information presented in an easy-to-read format for consumers and professionals.

Format
Guide
Audience
Behavioral Health Providers
Medical Providers
Other Team Members
Source
American Chronic Pain Association (ACPA)
Year
Resource Type
PDF
File Size
15.0 MB

FDA Public Workshop on Opioid Prescriber Education

This was a two-day virtual public workshop (which can now be re-watched) that convened regulators, clinical researchers, providers, patient advocates, and other stakeholders to exchange information and obtain input by discussing prescriber education's potential role in alleviating the evolving opioid and substance use crisis.
Format
Webinar/Video
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Communities
Policymakers and Payers
Source
Duke-Margolis Center for Health Policy / Food and Drug Administration (FDA)
Year
Resource Type
Video

Practical Tools for Prescribing and Promoting Buprenorphine in Primary Care Settings

This resource document provides practical, evidence-based information for primary care providers and practices on prescribing buprenorphine to individuals in need of intervention, including implementation considerations and strategies for primary care providers and primary care organizations.
Format
Guide
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Source
Substance Abuse and Mental Health Services Administration (SAMHSA)
Year
Resource Type
PDF
File Size
25.2 MB

Safe Use of Benzodiazepines: Clinical, Regulatory, and Public Health Perspectives

This two-day public workshop convened regulators, academic researchers, clinicians, patient advocates, and other stakeholders to share information underlying this action and gather input related to the safe use of benzodiazepines.
Format
Webinar/Video
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Communities
Policymakers and Payers
Source
Duke-Margolis Center for Health Policy / Food and Drug Administration (FDA)
Year
Resource Type
Video

State-Level Economic Costs of Opioid Use Disorder and Fatal Opioid Overdose — United States, 2017

These estimated costs of opioid use disorder and fatal opioid overdose and their per capita costs at the state level can assist federal and state decision makers in understanding the magnitude of opioid use disorder and fatal opioid overdose in their jurisdictions.
Format
Report/Paper/Issue Brief
Audience
Policymakers and Payers
States
Source
Centers for Disease Control and Prevention (CDC)
Year
Resource Type
PDF
File Size
217 KB